CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer

IF 4.6 2区 医学 Q2 IMMUNOLOGY Clinical & Translational Immunology Pub Date : 2024-03-18 DOI:10.1002/cti2.1499
Zhen-quan Duan, Yu-xian Li, Yuan Qiu, Yang Shen, Ying Wang, Yuan-yuan Zhang, Bao-hang Zhu, Xiao-hong Yu, Xue-ling Tan, Weisan Chen, Yuan Zhuang, Ping Cheng, Wei-jun Zhang, Quan-ming Zou, Dai-yuan Ma, Liu-sheng Peng
{"title":"CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer","authors":"Zhen-quan Duan,&nbsp;Yu-xian Li,&nbsp;Yuan Qiu,&nbsp;Yang Shen,&nbsp;Ying Wang,&nbsp;Yuan-yuan Zhang,&nbsp;Bao-hang Zhu,&nbsp;Xiao-hong Yu,&nbsp;Xue-ling Tan,&nbsp;Weisan Chen,&nbsp;Yuan Zhuang,&nbsp;Ping Cheng,&nbsp;Wei-jun Zhang,&nbsp;Quan-ming Zou,&nbsp;Dai-yuan Ma,&nbsp;Liu-sheng Peng","doi":"10.1002/cti2.1499","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>CD4<sup>+</sup> T cell helper and regulatory function in human cancers has been well characterised. However, the definition of tumor-infiltrating CD4<sup>+</sup> T cell exhaustion and how it contributes to the immune response and disease progression in human gastric cancer (GC) remain largely unknown.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A total of 128 GC patients were enrolled in the study. The expression of CD39 and PD-1 on CD4<sup>+</sup> T cells in the different samples was analysed by flow cytometry. GC-infiltrating CD4<sup>+</sup> T cell subpopulations based on CD39 expression were phenotypically and functionally assessed. The role of CD39 in the immune response of GC-infiltrating T cells was investigated by inhibiting CD39 enzymatic activity.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In comparison with CD4<sup>+</sup> T cells from the non-tumor tissues, significantly more GC-infiltrating CD4<sup>+</sup> T cells expressed CD39. Most GC-infiltrating CD39<sup>+</sup>CD4<sup>+</sup> T cells exhibited CD45RA<sup>−</sup>CCR7<sup>−</sup> effector–memory phenotype expressing more exhaustion-associated inhibitory molecules and transcription factors and produced less TNF-α, IFN-γ and cytolytic molecules than their CD39<sup>−</sup>CD4<sup>+</sup> counterparts. Moreover, <i>ex vivo</i> inhibition of CD39 enzymatic activity enhanced their functional potential reflected by TNF-α and IFN-γ production. Finally, increased percentages of GC-infiltrating CD39<sup>+</sup>CD4<sup>+</sup> T cells were positively associated with disease progression and patients' poorer overall survival.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our study demonstrates that CD39 expression defines GC-infiltrating CD4<sup>+</sup> T cell exhaustion and their immunosuppressive function. Targeting CD39 may be a promising therapeutic strategy for treating GC patients.</p>\n </section>\n </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.1499","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cti2.1499","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

CD4+ T cell helper and regulatory function in human cancers has been well characterised. However, the definition of tumor-infiltrating CD4+ T cell exhaustion and how it contributes to the immune response and disease progression in human gastric cancer (GC) remain largely unknown.

Methods

A total of 128 GC patients were enrolled in the study. The expression of CD39 and PD-1 on CD4+ T cells in the different samples was analysed by flow cytometry. GC-infiltrating CD4+ T cell subpopulations based on CD39 expression were phenotypically and functionally assessed. The role of CD39 in the immune response of GC-infiltrating T cells was investigated by inhibiting CD39 enzymatic activity.

Results

In comparison with CD4+ T cells from the non-tumor tissues, significantly more GC-infiltrating CD4+ T cells expressed CD39. Most GC-infiltrating CD39+CD4+ T cells exhibited CD45RACCR7 effector–memory phenotype expressing more exhaustion-associated inhibitory molecules and transcription factors and produced less TNF-α, IFN-γ and cytolytic molecules than their CD39CD4+ counterparts. Moreover, ex vivo inhibition of CD39 enzymatic activity enhanced their functional potential reflected by TNF-α and IFN-γ production. Finally, increased percentages of GC-infiltrating CD39+CD4+ T cells were positively associated with disease progression and patients' poorer overall survival.

Conclusion

Our study demonstrates that CD39 expression defines GC-infiltrating CD4+ T cell exhaustion and their immunosuppressive function. Targeting CD39 may be a promising therapeutic strategy for treating GC patients.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CD39 表达确定了与人类胃癌生存率低和免疫逃避相关的 CD4+ T 细胞衰竭情况
目标 CD4+ T 细胞在人类癌症中的辅助和调节功能已得到很好的描述。然而,肿瘤浸润性 CD4+ T 细胞衰竭的定义以及它如何导致人类胃癌(GC)的免疫反应和疾病进展在很大程度上仍是未知数。 方法 本研究共纳入了 128 例胃癌患者。流式细胞术分析了不同样本中 CD4+ T 细胞上 CD39 和 PD-1 的表达。根据 CD39 表达对 GC 浸润 CD4+ T 细胞亚群进行了表型和功能评估。通过抑制 CD39 酶的活性,研究了 CD39 在 GC 浸润 T 细胞免疫反应中的作用。 结果 与来自非肿瘤组织的 CD4+ T 细胞相比,表达 CD39 的 GC 浸润 CD4+ T 细胞明显增多。大多数GC浸润的CD39+CD4+ T细胞表现出CD45RA-CCR7-效应记忆表型,表达更多衰竭相关抑制分子和转录因子,产生的TNF-α、IFN-γ和细胞溶解分子少于CD39-CD4+同类细胞。此外,体内抑制 CD39 酶活性可提高它们的功能潜力,这体现在 TNF-α 和 IFN-γ 的产生上。最后,GC 浸润 CD39+CD4+ T 细胞百分比的增加与疾病进展和患者较差的总生存率呈正相关。 结论 我们的研究表明,CD39 的表达决定了 GC 浸润 CD4+ T 细胞的衰竭及其免疫抑制功能。以 CD39 为靶点可能是治疗 GC 患者的一种有前途的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical & Translational Immunology
Clinical & Translational Immunology Medicine-Immunology and Allergy
CiteScore
12.00
自引率
1.70%
发文量
77
审稿时长
13 weeks
期刊介绍: Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. The Journal covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
期刊最新文献
Natural killer cell antibody-dependent cellular cytotoxicity to Plasmodium falciparum is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients Inhibitory effect of hydroxychloroquine on glucocorticoid-induced osteoporosis in lupus therapy Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan-cancer analysis Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1